Merck Life Science A/S: Financial statements 2019
CVR: 20830131
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 53,447,114 and a net result of DKK 27,387,479 compared with DKK 16,709,359 the year before. That is an increase of 98.7% compared with the year before. Equity in the 2019 report amounted to DKK 135,690,861. The solvency ratio was 74.7%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 53,447,114
- Profit/Loss
- DKK 27,387,479
- Equity
- DKK 135,690,861
- Total Assets
- DKK 181,671,113
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 53.4M | 27.4M | 135.7M | 9 |
| 2018 | - | 26.9M | 16.7M | 67.1M | 14 |
| 2017 | - | 21.3M | 8.6M | 50.4M | 16 |
| 2016 | - | 20.3M | 6.2M | 41.7M | 17 |
| 2015 | - | 34.3M | 7.4M | 35.5M | 17 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
On November 4, 2019, the company changed its name from SIGMA-ALDRICH DENMARK A/S to Merck Life Science A/S.
As of June 1, 2019, Enrique Álvarez Fernández has joined the board of directors of Merck Life Science A/S.
As of June 1, 2019, Renée Christine Tunold has left the board of directors of Merck Life Science A/S.
As of June 1, 2019, Enrique Álvarez Fernández is registered as adm. dir. of Merck Life Science A/S.
As of June 1, 2019, Tiina Marjatta Puhakka has stepped down as adm. dir. of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2018. Gross profit came to DKK 26,897,123, and the net result was DKK 16,709,359.
On April 10, 2019, the company changed its name from SIGMA-ALDRICH DENMARK ApS to SIGMA-ALDRICH DENMARK A/S.
As of April 9, 2019, Jeanette Sandholmen has joined the board of directors of Merck Life Science A/S.
As of April 9, 2019, Tiina Marjatta Puhakka has joined the board of directors of Merck Life Science A/S.
As of April 8, 2019, Jeanette Sandholmen has left the board of directors of Merck Life Science A/S.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.
